Currently, CR Bard Inc (NYSE:BCR) has a Strong Buy using Louis Navellier's investing methodology and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking BCR has had from Portfolio Grader for 3 months.

CR Bard Inc (NYSE:BCR) is a $24.3 billion in market value constituent of the Health Care Equipment & Supplies GICS industry group where the stock's Portfolio Grader ranking places it 22 among the 161 companies in this industry group, placing it among the leaders. BCR is ranked among the sector leaders with a ranking of 64 among the 781 companies in the sector and number 364 in the 5000 company Portfolio Grader company universe.

Currently, CR Bard Inc (NYSE:BCR) has a Strong Buy using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 3 months.

Portfolio Grader currently ranks CR Bard Inc (NYSE:BCR) a Strong Buy. The methods for investing incorporated in this analytical tool developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. BCR has maintained this ranking for 3 months.